Literature DB >> 29844759

Cannabidiol and Serum Antiepileptic Drug Levels: The ABCs of CBD With AEDs.

Bernard S Chang.   

Abstract

Entities:  

Year:  2018        PMID： 29844759      PMCID： PMC5967591          DOI： 10.5698/1535-7597.18.1.33

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  5 in total

Review 1.  Cannabinoids in the Treatment of Epilepsy.

Authors:  Daniel Friedman; Orrin Devinsky
Journal:  N Engl J Med       Date:  2015-09-10       Impact factor: 91.245

Review 2.  Cannabinoids in treatment-resistant epilepsy: A review.

Authors:  Brooke K O'Connell; David Gloss; Orrin Devinsky
Journal:  Epilepsy Behav       Date:  2017-02-08       Impact factor: 2.937

3.  Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Authors:  Orrin Devinsky; J Helen Cross; Linda Laux; Eric Marsh; Ian Miller; Rima Nabbout; Ingrid E Scheffer; Elizabeth A Thiele; Stephen Wright
Journal:  N Engl J Med       Date:  2017-05-25       Impact factor: 91.245

4.  Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.

Authors:  Orrin Devinsky; Eric Marsh; Daniel Friedman; Elizabeth Thiele; Linda Laux; Joseph Sullivan; Ian Miller; Robert Flamini; Angus Wilfong; Francis Filloux; Matthew Wong; Nicole Tilton; Patricia Bruno; Judith Bluvstein; Julie Hedlund; Rebecca Kamens; Jane Maclean; Srishti Nangia; Nilika Shah Singhal; Carey A Wilson; Anup Patel; Maria Roberta Cilio
Journal:  Lancet Neurol       Date:  2015-12-24       Impact factor: 44.182

5.  Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.

Authors:  Alexandra L Geffrey; Sarah F Pollack; Patricia L Bruno; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2015-06-26       Impact factor: 5.864
  5 in total
  2 in total

Review 1.  Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine.

Authors:  Susanne Schubert-Bast; Adam Strzelczyk
Journal:  Ther Adv Neurol Disord       Date:  2021-07-17       Impact factor: 6.570

2.  Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment.

Authors:  Claudia Taborda Gómez; Fabiana Lairion; Marisa Repetto; Miren Ettcheto; Amalia Merelli; Alberto Lazarowski; Jerónimo Auzmendi
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.